Region:Middle East
Author(s):Geetanshi
Product Code:KRAA4143
Pages:86
Published On:January 2026

By Product & Service:The product and service segmentation of the market includes various offerings that cater to the diverse needs of researchers and organizations involved in gene synthesis. The dominant sub-segment is Gene Synthesis Services, which is preferred due to its ability to provide customized solutions for complex genetic constructs and the limited in?house synthesis capacity at many regional laboratories. This is followed by Gene Synthesis Kits & Reagents, which are essential for laboratory workflows involving PCR, cloning, and DNA assembly. The demand for Oligonucleotide Synthesis is also significant, driven by its applications in diagnostics, qPCR, next-generation sequencing workflows, and therapeutics research. Cloning & Assembly Services are gaining traction as researchers seek efficient methods for gene manipulation, plasmid construction, and pathway engineering, often via outsourced service providers. Other services, such as related bioinformatics support and design tools, complement these primary offerings and support end users in academia, hospitals, and industry.

By Gene Type:The gene type segmentation includes various categories that cater to specific research needs. Standard Genes are the most widely used due to their broad applications in basic research, expression studies, and educational settings. Complex & GC-rich Genes are gaining popularity as researchers explore more intricate genetic constructs, including challenging templates for structural biology, enzyme engineering, and pathway optimization. Customized Gene Fragments are increasingly in demand for tailored research projects, modular cloning, and rapid prototyping of constructs, while Synthetic Gene Libraries are utilized for high-throughput screening, protein engineering, and directed evolution. Other gene types, including regulatory sequences and non-coding constructs, also play a role in niche applications within genomics and synthetic biology.

The United Arab Emirates Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Thermo Fisher Scientific Inc., Integrated DNA Technologies, Inc. (IDT), GenScript Biotech Corporation, Eurofins Genomics, Twist Bioscience Corporation, Precigen, Inc. (formerly Synthetic Genomics), Bio Basic Inc., Bioneer Corporation, ATUM, Codex DNA, Inc. (formerly DNA2.0), LGC Biosearch Technologies (LGC Group), GeneArt Gene Synthesis (Thermo Fisher Scientific), Jena Bioscience GmbH, Genomatix Software GmbH, Other Emerging Regional & Global Players contribute to innovation, geographic expansion, and service delivery in this space, often serving UAE customers through regional distribution partners, online ordering platforms, and collaborations with local research institutions.
The future of the gene synthesis market in the UAE appears promising, driven by ongoing advancements in biotechnology and increasing government support. As the demand for personalized medicine and innovative agricultural solutions rises, the market is expected to expand significantly in future. Collaborations between research institutions and private companies will likely enhance the development of cost-effective synthesis methods, while the integration of artificial intelligence in gene synthesis processes will streamline operations and improve outcomes, positioning the UAE as a leader in this field.
| Segment | Sub-Segments |
|---|---|
| By Product & Service | Gene Synthesis Services Gene Synthesis Kits & Reagents Oligonucleotide Synthesis Cloning & Assembly Services Others |
| By Gene Type | Standard Genes Complex & GC?rich Genes Customized Gene Fragments Synthetic Gene Libraries Others |
| By Application (Research Use Only) | Synthetic Biology & Metabolic Engineering Genetic Engineering & Cloning Vaccine & Therapeutics R&D Diagnostics & Assay Development CRISPR & Genome Editing Research Others |
| By End-User | Academic & Research Institutes Biopharmaceutical & Diagnostics Companies Contract Research Organizations (CROs) Government & Non?profit Research Centers Others |
| By Mode | Contract / Outsourced In?house |
| By Region | Abu Dhabi Dubai Sharjah Northern Emirates Free Zones (Science & Technology Parks) |
| By Funding Source (Research Use Only) | Government Grants & National Programs University & Institutional Budgets Corporate & Industrial R&D Funding Venture Capital & Private Investments Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Pharmaceutical Applications | 100 | R&D Directors, Product Development Managers |
| Agricultural Biotechnology | 80 | Research Scientists, Agronomists |
| Academic Research Institutions | 70 | Laboratory Managers, Principal Investigators |
| Clinical Research Organizations | 60 | Clinical Project Managers, Regulatory Affairs Specialists |
| Startups in Synthetic Biology | 50 | Founders, Technical Leads |
The United Arab Emirates Gene Synthesis Research Use Market is valued at approximately USD 6 million, reflecting its growth driven by advancements in biotechnology and increasing investments in research and development across various sectors.